Bandage versus below‐elbow cast for buckle or minimally displaced fracture in children | ||||||
Patient or population: children with stable wrist fracture, predominantly buckle (torus) fracturesa Settings: hospital clinic Intervention: Soft or elasticated bandageb for 3 to 4 weeks Comparison: Below‐elbow cast for 3 to 4 weeks | ||||||
Outcomes | Illustrative comparative risks* (95% CI) | Relative effect (95% CI) | No of Participants (studies) | Quality of the evidence (GRADE) | Comments | |
Assumed risk | Corresponding risk | |||||
Below‐elbow cast | Bandage | |||||
Pain with VAS (0 to 100; worst pain) at 1 week | The mean score in the study control group was 20 | The mean score in the intervention group was 6 higher (1.31 lower to 13.31 higher) | ‐ | 89 children (1 study) | ⊕⊝⊝⊝ very lowc | The 95% CI is unlikely to include a clinically important effect. There was also very low‐quality evidence of less pain in the bandage group in 1 study (39 children), and little difference in pain during device use or requirement for analgesic in another study (53 participants)d |
Discomfort during use of device (up to 4 weeks) | 572 per 1000e | 58 (6 to 389) | RR 0.10 (0.01 to 0.68) | 39 children (1 study) |
⊕⊝⊝⊝ very lowf | Another study (89 participants at 1 week) also reported "significantly less" discomfort in the bandage group; mainly in relation to itchingg |
Patient experience: children found treatment was convenient (4 weeks follow‐up) |
143 per 1000e | 946 per 1000 (331 to 1000) | RR 6.61 (2.31 to 18.96) |
39 children (1 study) |
⊕⊝⊝⊝ very lowh | In this study, all 18 participants followed up in the bandage group had removed their bandage by 2 weeks |
Time to return to former activities | See comment | See comment | Not estimable | ‐ | See comment | This outcome was not reported |
Skin problems | See comment | See comment | Not estimable | ‐ | See comment | 1 trial (39 participants) reported no skin problems |
Serious adverse events: refracture | See comment | See comment | Not estimable | ‐ | See comment | No children developed a serious adverse event in the 2 studies (139 children) followed up at 3 to 4 weeks |
Health‐related quality of life | See comment | See comment | Not estimable | ‐ | See comment | This outcome was not reported |
Cast changes and number of outpatient visits (3 to 6 weeks follow‐up) | See comment | See comment | Not estimable | ‐ | See comment | Data not provided. 3 studies (181 children) reported on treatment failure (treatment change or extended use due to delayed union)i |
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: Confidence interval; RR: Risk Ratio; VAS: visual analogue scale | ||||||
GRADE Working Group grades of evidence High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality: We are very uncertain about the estimate. |